Literature DB >> 31415142

Reversible Gene Regulation in Mammalian Cells Using Riboswitch-Engineered Vesicular Stomatitis Virus Vector.

Kei Takahashi1, Yohei Yokobayashi1.   

Abstract

Synthetic riboswitches based on small molecule-responsive self-cleaving ribozymes (aptazymes) embedded in the untranslated regions (UTRs) allow chemical control of gene expression in mammalian cells. In this work, we used a guanine-responsive aptazyme to control transgene expression from a replication-incompetent vesicular stomatitis virus (VSV) vector. VSV is a nonsegmented, negative-sense, cytoplasmic RNA virus that replicates without DNA intermediates, and its applications for vaccines and oncolytic viral therapy are being explored. By inserting the guanine-activated ribozyme in the 3' UTRs of viral genes and transgenes, GFP expression from the VSV vector in mammalian cells was repressed by as much as 26.8-fold in the presence of guanine. Furthermore, we demonstrated reversible regulation of a transgene (secreted NanoLuc) by adding and withdrawing guanine from the medium over the course of 12 days. In summary, our riboswitch-controlled VSV vector allows robust, long-term, and reversible regulation of gene expression in mammalian cells without the risk of undesirable genomic integration.

Entities:  

Keywords:  RNA replicon; RNA virus; aptazyme; riboswitch

Mesh:

Substances:

Year:  2019        PMID: 31415142     DOI: 10.1021/acssynbio.9b00177

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  5 in total

Review 1.  Engineering synthetic RNA devices for cell control.

Authors:  Peter B Dykstra; Matias Kaplan; Christina D Smolke
Journal:  Nat Rev Genet       Date:  2022-01-04       Impact factor: 59.581

2.  Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9.

Authors:  Elizabeth C Eckert; Rebecca A Nace; Jason M Tonne; Laura Evgin; Richard G Vile; Stephen J Russell
Journal:  Mol Ther Oncolytics       Date:  2019-12-14       Impact factor: 7.200

3.  Chemogenetic ON and OFF switches for RNA virus replication.

Authors:  E Heilmann; J Kimpel; B Hofer; A Rössler; I Blaas; L Egerer; T Nolden; C Urbiola; H G Kräusslich; G Wollmann; D von Laer
Journal:  Nat Commun       Date:  2021-03-01       Impact factor: 14.919

4.  Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro.

Authors:  Chengle Zhuang; Changshui Zhuang; Qun Zhou; Xueting Huang; Yaoting Gui; Yongqing Lai; Shangqi Yang
Journal:  Front Mol Biosci       Date:  2021-03-19

5.  Development of an RNA Virus-Based Episomal Vector Capable of Switching Transgene Expression.

Authors:  Yusuke Yamamoto; Keizo Tomonaga; Tomoyuki Honda
Journal:  Front Microbiol       Date:  2019-11-06       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.